Oakland, CA: New Harbinger Publications.
Many wellness clinics now offer both treatments because they complement one another throughout a patient's transformation journey
Most patients should have follow-up appointments every 3-6 months during tirzepatide therapy, with more frequent visits during dose titration or if concerns arise
Lose 13.6% of your body weight on average. One daily tablet = comparable results to injectable Wegovy. Eligible patients lost an average of 13.6% of their body weight in a 64-week clinical trial evaluating 25 mg oral semaglutide compared to those on 2.4 mg injectable semaglutide who lost an average of 14.9% of their body weight in a 68-week clinical trial
Signs of gallbladder problems, including right upper abdominal pain, jaundice, or clay-colored stools, warrant urgent assessment, as these medications can increase gallstone risk, particularly during rapid weight loss